Daniel E. Furst
University of Southern California(US)University of California, Los Angeles(US)Los Angeles City College(US)Scleroderma Foundation(US)University of Florence(IT)
Publications by Year
Research Areas
Systemic Sclerosis and Related Diseases, Rheumatoid Arthritis Research and Therapies, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Dermatologic Treatments and Research, Inflammatory Myopathies and Dermatomyositis
Most-Cited Works
- → 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative(2013)3,340 cited
- → 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis(2015)2,762 cited
- → Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial(2003)1,756 cited
- → Cyclophosphamide versus Placebo in Scleroderma Lung Disease(2006)1,649 cited
- → 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia(2012)1,528 cited
- → American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis(2008)1,489 cited